top of page

SPEAKERS

Vanessa.png
Filip Delport_edited.png
Tom Robinson.png

​DR. FILIP DELPORT

-

Fox Biosystems offers innovative platforms for bioprocess monitoring. Using Fiber Optic Surface Plasmon Resonance (FO-SPR) sensors, the technology allows for a cost-efficient and flexible detection of molecular interactions. Filip will talk about their technology, the process of going from an initial concept to a complete product and the challenges faced by biotechnology start-ups.  

​DR. TOM ROBINSON

Minimal cells created, manipulated and analysed using microfluidic systems

Giant unilamellar vesicles (GUVs) are now considered the gold standard for the bottom-up construction of synthetic minimal cells. However, traditional techniques lack the ability to encapsulate the required machinery or to control their sizes. Microfluidic systems, on the other hand, are ideally suited to this challenging task (Robinson. Advanced Biosystems, 2019). First, we present a microfluidic platform based on droplet technology which is able to produce monodisperse biomimetic GUVs with high encapsulation - ideal for synthetic cell construction. Microfluidics is also used to produce artificial minimal cells with multiple membrane compartments, either by encapsulation of smaller vesicles or by complete on-chip methods. Next, we present novel methods for the capture and analysis of artificial cells (Robinson et al., Biomicrofluidics 2013; Yandralli & Robinson, Lab on a Chip 2019) including a new high-throughput device able to perform up to 8 separate experiments with 800 GUVs each as well as an integrated platform able to produce and capture GUVs in the same device (Yandralli & Robinson, submitted). Finally, we present two applications of our multi-compartment minimal cells. The first system we designed to exhibit self-organisation of its internal synthetic organelles via a simple biotin-avidin adhesion system. More advanced constructs are triggered externally by (i) light using protein-protein bindings or (ii) via the addition of ssDNA for DNA-DNA interactions. Finally, in an effort to reflect the complexity of eukaryotic cells we have designed, from the bottom-up, an enzymatic cascade pathway which takes full advantage of multiple membrane compartments with distinct reconstituted membrane pores. This synthetic signalling cascade is triggered by first capturing them in our microfluidic devices and second by using microfluidic flow to controllably deliver the chemical inputs.

​DR. VANESSA LA POINTE

Directing cell fate in regenerative medicine

Regenerative medicine holds the promise to transform healthcare by curing a number of chronic diseases. Various approaches involving (stem) cells, biomaterials and combinations thereof have led to new therapies, yet there are still major challenges to overcome, especially in our ability to reliably direct cell fate. In this talk, I will discuss some strategies that scientists can use to overcome these challenges.

Rafael Galupa.jpg
Patrick Van Dijck.png
Wim van Hecke.jpg

​DR. RAFAEL GALUPA

-

Rafael Galupa is a postdoctoral researcher in the Crocker lab, at EMBL Heidelberg, where he is using synthetic biology tools in the early fly embryos to explore how enhancers and gene regulatory networks decode positional information during development. He will present recent efforts on establishing synthetic enhancers and networks.

​PROF. PATRICK VAN DIJCK

-

Prof. Patrick Van Dijck is an expert in molecular microbiology and senior lecturer at the Faculty of Science, KU Leuven. His lab’s research mainly focuses on the threat fungi pose to plants, animals and humans. Prof. Van Dijck will talk about his research and his work as the CSO of StixFresh, a biotech start-up developing stickers to keep fruits fresh.

DR. WIM VAN HECKE​

-

Icometrix is the world leader in software solutions to obtain clinically meaningful data from brain MRI and CT scans for patients with neurological disorders. Today, icometrix is internationally active, the FDA cleared icobrain software is used in 100+ hospitals and icometrix works with the largest pharmaceutical and health tech companies. Wim Van Hecke is the founder and CEO of icometrix.

Gerard Govers.png

​PROF. GERARD GOVERS

-

Description coming soon!

WORKSHOP, JURY, AND PANEL MEMBERS

Johan Robben.png
Yannick.png
Vitor Pinheiro.jpg

PROF. JOHAN ROBBEN (JURY)​

-

Prof. dr. Johan Robben is vice dean for education and senior lecturer biochemistry and molecular biology at the Faculty of Science, KU Leuven. His research at the department of Chemistry mainly focuses on molecular evolution of nucleic acid-interacting proteins. As an experienced advisor to multiple KU Leuven iGEM teams and judge at the iGEM 2013 Jamboree, he can provide your team with productive feedback on your presentation.

​YANNICK DILLEN (WORKSHOP)

-

Yannick Dillen is lecturer at Vlerick Business School where he teaches courses on entrepreneurship and growth management. In this workshop, he will give the participants some insights in ‘start-up essentials’, such as ideation, prototyping, business modelling and the lean start-up methodology.

​DR. VITOR PINHEIRO (JURY, PANEL)

-

​Prof. Vitor Pinheiro started his career in Cambridge (UK) as an undergraduate in Natural Sciences and later as a PhD and post-doctoral researcher. He started his independent research career in London at UCL, before moving to Belgium. He is now a group leader at the Rega Institute for Medical Research at KU Leuven. Prof. Pinheiro is a pioneer in Xenobiology, having developed the first synthetic genetic material, and he participates actively in the Synthetic Biology community.

Niek Savelkoul2.jpg
Vitor Pinheiro.jpg
Benjamien.png

​DR. VITOR PINHEIRO (JURY, PANEL)

-

​Prof. Vitor Pinheiro started his career in Cambridge (UK) as an undergraduate in Natural Sciences and later as a PhD and post-doctoral researcher. He started his independent research career in London at UCL, before moving to Belgium. He is now a group leader at the Rega Institute for Medical Research at KU Leuven. Prof. Pinheiro is a pioneer in Xenobiology, having developed the first synthetic genetic material, and he participates actively in the Synthetic Biology community.

​NIEK SAVELKOUL (AFTER iGEM)

-

What happens after the iGEM competition? This talk will show the possibilities After iGEM offers in a narrative session. There is room for a Q&A session on the last two months of the competition and the After iGEM program.

DR. BENJAMIEN MOEYAERT (PANEL)​

-

Benjamien obtained his PhD in Biochemistry and Biotechnology at the Department of Chemistry at KU Leuven in 2015 with his work on the design of fluorescent proteins for superresolution microscopy. He then did a postdoc at the prestigious HHMI Janelia Research Campus in Virginia, USA, where he developed optical tools for the identification of active neuronal populations. Since 2018, he is again affiliated with the Department of Chemistry at KU Leuven as an FWO postdoctoral researcher. He uses techniques of protein engineering and molecular biology to design novel optogenetic tools for the perturbation of cell physiology. In 2008, Benjamien was the driving force behind the very first iGEM team of KU Leuven.

  • 1161954-64
  • 107175-64
bottom of page